Isotretinoin Sandoz Sandoz

Isotretinoin, the active ingredient in Isotretinoin Sandoz, is a retinoid presented as an oral capsule for oral use. It is indicated for the treatment of severe nodular acne and acne vulgaris that has not responded to conventional therapies.

GNH USA supplies Isotretinoin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Our distribution network ensures timely delivery and reliable supply chain management across diverse markets.

Isotretinoin is a retinoid that targets severe forms of acne and related inflammatory skin conditions. - Severe nodular acne: reduces the number and size of nodular lesions, leading to clearer skin. - Acne vulgaris refractory to other therapies: achieves significant reduction in inflammatory lesions when other treatments have failed. - Moderate to severe acne vulgaris: improves overall lesion count and prevents new lesion formation.

Isotretinoin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dry skin and lips: excessive dryness and cracking of the epidermis and vermilion border. - Cheilitis: inflammation and fissuring of the lips. - Mild elevation of liver enzymes: transient increase in ALT/AST. - Transient hypertriglyceridemia: temporary rise in blood triglyceride levels.

Serious or Rare Side Effects: - Severe hepatotoxicity: significant liver injury requiring discontinuation. - Pancreatitis: inflammation of the pancreas associated with high triglycerides. - Psychiatric effects: depression, suicidal ideation, or mood changes. - Birth defects: severe congenital malformations if exposure occurs during pregnancy.

When prescribing isotretinoin, clinicians should observe several safety precautions to minimize risks. - Pregnancy testing: confirm negative pregnancy test before initiating therapy and use effective contraception throughout treatment. - Baseline labs: obtain liver function tests and lipid profile prior to start and monitor periodically. - Teratogenic risk: avoid use in pregnant or nursing women due to high risk of fetal malformations. - Psychiatric monitoring: assess for depression or mood changes during therapy. - Dose adjustments: modify dose in patients with hepatic impairment or hyperlipidaemia as guided by laboratory results. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture and light.

Isotretinoin can interact with several medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Tetracyclines (e.g., doxycycline): increased risk of intracranial hypertension when combined. - Vitamin A supplements: additive toxicity leading to severe hypervitaminosis A.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce isotretinoin plasma levels, requiring monitoring of acne response. - Systemic corticosteroids: may blunt anti‑inflammatory effect of isotretinoin. - Antifungal azoles (e.g., ketoconazole): can increase isotretinoin concentrations, necessitating dose adjustment.